Super League Enterprise, Inc. (SLE) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
23/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseSLE / S&P -19.73% / 15.20% |
LoseSLE / S&P -14.30% / 15.00% |
LoseSLE / S&P SLE unavailable / 50.40% |
| 2026-Q10/3 |
LoseSLE / S&P -49.54% / -4.33% |
LoseSLE / S&P -20.86% / 11.30% |
LoseSLE / S&P SLE unavailable / 27.70% |
| 2025-Q40/3 |
LoseSLE / S&P -86.39% / 2.65% |
LoseSLE / S&P -29.91% / 9.00% |
LoseSLE / S&P SLE unavailable / 13.40% |
| 2025-Q30/3 |
LoseSLE / S&P -3.13% / 8.12% |
LoseSLE / S&P -48.05% / 4.61% |
LoseSLE / S&P SLE unavailable / 13.45% |
| 2025-Q20/3 |
LoseSLE / S&P -50.69% / 10.94% |
LoseSLE / S&P -45.76% / 4.83% |
LoseSLE / S&P SLE unavailable / 10.63% |
| 2025-Q10/3 |
LoseSLE / S&P -61.97% / -4.27% |
LoseSLE / S&P -43.42% / 4.98% |
LoseSLE / S&P SLE unavailable / 10.57% |
| 2024-Q40/3 |
LoseSLE / S&P -0.64% / 2.41% |
LoseSLE / S&P -35.48% / 5.25% |
LoseSLE / S&P SLE unavailable / 6.15% |
| 2024-Q30/3 |
LoseSLE / S&P -22.25% / 5.89% |
LoseSLE / S&P -1.87% / 5.89% |
LoseSLE / S&P SLE unavailable / 6.11% |
| 2024-Q21/3 |
LoseSLE / S&P -62.79% / 4.28% |
WinSLE / S&P 25.12% / 5.38% |
LoseSLE / S&P SLE unavailable / 5.12% |
| 2024-Q12/3 |
WinSLE / S&P 41.45% / 10.56% |
WinSLE / S&P 35.02% / 5.71% |
LoseSLE / S&P SLE unavailable / 5.59% |
| 2023-Q41/3 |
LoseSLE / S&P -12.64% / 11.69% |
WinSLE / S&P 27.45% / 6.81% |
LoseSLE / S&P SLE unavailable / 7.78% |
| 2023-Q31/3 |
LoseSLE / S&P -77.11% / -3.27% |
WinSLE / S&P 21.03% / 7.52% |
LoseSLE / S&P SLE unavailable / -5.03% |
| 2023-Q21/3 |
LoseSLE / S&P -31.53% / 8.74% |
WinSLE / S&P 12.09% / 9.50% |
LoseSLE / S&P SLE unavailable / -8.57% |
| 2023-Q12/3 |
WinSLE / S&P 65.18% / 7.50% |
WinSLE / S&P 31.26% / 10.77% |
LoseSLE / S&P SLE unavailable / -15.69% |
| 2022-Q41/3 |
LoseSLE / S&P -50.22% / 7.56% |
WinSLE / S&P 68.60% / 11.88% |
LoseSLE / S&P SLE unavailable / -17.99% |
| 2022-Q31/3 |
LoseSLE / S&P -33.82% / -4.88% |
WinSLE / S&P 199.70% / 13.47% |
LoseSLE / S&P SLE unavailable / -1.41% |
| 2022-Q21/3 |
LoseSLE / S&P -45.74% / -16.10% |
WinSLE / S&P 429.71% / 13.71% |
LoseSLE / S&P SLE unavailable / 11.04% |
| 2022-Q11/3 |
LoseSLE / S&P -20.34% / -4.60% |
WinSLE / S&P 461.56% / 15.97% |
LoseSLE / S&P SLE unavailable / 42.23% |
| 2021-Q41/3 |
LoseSLE / S&P -24.12% / 11.03% |
WinSLE / S&P 465.46% / 15.00% |
LoseSLE / S&P SLE unavailable / 96.40% |
| 2021-Q31/3 |
LoseSLE / S&P -42.30% / 0.58% |
WinSLE / S&P 304.40% / 10.77% |
LoseSLE / S&P SLE unavailable / 69.42% |
| 2021-Q21/3 |
LoseSLE / S&P -23.44% / 8.55% |
WinSLE / S&P 185.75% / 6.58% |
LoseSLE / S&P SLE unavailable / 51.81% |
| 2021-Q12/3 |
WinSLE / S&P 148.76% / 6.17% |
WinSLE / S&P 142.02% / -1.06% |
LoseSLE / S&P SLE unavailable / 7.39% |
| 2020-Q42/3 |
WinSLE / S&P 54.64% / 12.15% |
WinSLE / S&P 90.41% / -3.72% |
LoseSLE / S&P SLE unavailable / -33.42% |
| 2020-Q31/3 |
LoseSLE / S&P -23.75% / 8.93% |
WinSLE / S&P 25.98% / -2.04% |
LoseSLE / S&P SLE unavailable / -27.10% |
| 2020-Q21/3 |
LoseSLE / S&P 9.09% / 20.54% |
WinSLE / S&P 14.35% / -0.46% |
LoseSLE / S&P SLE unavailable / -27.11% |
| 2020-Q11/3 |
WinSLE / S&P -6.78% / -19.60% |
LoseSLE / S&P -7.55% / 3.47% |
LoseSLE / S&P SLE unavailable / -14.75% |
| 2019-Q40/3 |
LoseSLE / S&P -45.24% / 9.07% |
LoseSLE / S&P 3.63% / 5.36% |
LoseSLE / S&P SLE unavailable / 2.99% |
| 2019-Q30/3 |
LoseSLE / S&P -49.59% / 1.70% |
LoseSLE / S&P SLE unavailable / 5.02% |
LoseSLE / S&P SLE unavailable / 0.21% |
| 2019-Q21/3 |
WinSLE / S&P 6.21% / 4.30% |
LoseSLE / S&P SLE unavailable / 6.64% |
LoseSLE / S&P SLE unavailable / 8.65% |
| 2019-Q10/3 |
LoseSLE / S&P SLE unavailable / 13.65% |
LoseSLE / S&P SLE unavailable / 8.12% |
LoseSLE / S&P SLE unavailable / 14.29% |
| 2018-Q40/3 |
LoseSLE / S&P SLE unavailable / -13.52% |
LoseSLE / S&P SLE unavailable / 9.05% |
LoseSLE / S&P SLE unavailable / 18.23% |
| 2018-Q30/3 |
LoseSLE / S&P SLE unavailable / 7.71% |
LoseSLE / S&P SLE unavailable / 10.21% |
LoseSLE / S&P SLE unavailable / 19.06% |
| 2018-Q20/3 |
LoseSLE / S&P SLE unavailable / 3.43% |
LoseSLE / S&P SLE unavailable / 9.03% |
LoseSLE / S&P SLE unavailable / 14.46% |
| 2018-Q10/3 |
LoseSLE / S&P SLE unavailable / -0.76% |
LoseSLE / S&P SLE unavailable / 7.68% |
LoseSLE / S&P SLE unavailable / 12.46% |
| 2017-Q40/3 |
LoseSLE / S&P SLE unavailable / 6.64% |
LoseSLE / S&P SLE unavailable / 7.03% |
LoseSLE / S&P SLE unavailable / 13.82% |
| 2017-Q30/3 |
LoseSLE / S&P SLE unavailable / 4.48% |
LoseSLE / S&P SLE unavailable / 5.68% |
LoseSLE / S&P SLE unavailable / 17.57% |
| 2017-Q20/3 |
LoseSLE / S&P SLE unavailable / 3.09% |
LoseSLE / S&P SLE unavailable / 4.83% |
LoseSLE / S&P SLE unavailable / 17.74% |
| 2017-Q10/3 |
LoseSLE / S&P SLE unavailable / 6.07% |
LoseSLE / S&P SLE unavailable / 3.67% |
LoseSLE / S&P SLE unavailable / 13.32% |
| 2016-Q40/3 |
LoseSLE / S&P SLE unavailable / 3.82% |
LoseSLE / S&P SLE unavailable / 2.09% |
LoseSLE / S&P SLE unavailable / 7.05% |
| 2016-Q30/3 |
LoseSLE / S&P SLE unavailable / 3.85% |
LoseSLE / S&P SLE unavailable / 0.20% |
LoseSLE / S&P SLE unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | SLE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -90.58% | 20.78% |
| Annualized return | -90.58% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | SLE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.99% | 83.14% |
| Annualized return | -84.31% | 12.86% |
10Y · 2019-02-26 to 2026-08-27
| Metric | SLE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -63.50% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Healthcare Triangle, Inc. (HCTI) | United States | $0.011B | |
| Algorhythm Holdings, Inc. (RIME) | United States | $0.003B | -0.61 |
| Fusemachines Inc. (FUSE) | United States | $0.017B | |
| CREATIVE REALITIES, INC. (CREX) | United States | $0.036B | -2.64 |
| STEM, INC. (STEM) | United States | $0.038B | -1.03 |
| Brand Engagement Network Inc. (BNAI) | United States | $0.048B | |
| Odysight.ai Inc. (ODYS) | $0.054B | -3.84 | |
| CSP INC /MA/ (CSPI) | United States | $0.077B | -117.69 |
| CID Holdco, Inc. (DAIC) | United States | $0.103B | |
| WIDEPOINT CORP (WYY) | United States | $0.109B | -137.61 |